Home » Newsletters » BioWorld

BioWorld

Jan. 15, 1993

View Archived Issues

FDA APPROVES ARGUS TRIALS

CIBUS TAKES REVERSE APPROACH

B7 GENE PRODUCT PRIMES KILLER T CELLS

SEC APPROVES APPLIED BIO MERGER

SCIOS NOVA SELLS RECEPTOR SCREENING BUSINESS

DELIVERING NERVE GROWTH FACTOR TO BRAIN

SANDOZ INVESTS $75M IN NEUROSCIENCES INSTITUTE

RAC OKS 'COMPASSIONATE' USE OF GENE THERAPY

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026